Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Amphastar Pharmaceuticals, Inc. Director's Dealing 2014

Aug 20, 2014

10216_dirs_2014-08-19_958b7195-024c-4264-827a-be22779b5a92.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2014-08-15

Reporting Person: Koo Richard (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-08-15 Common Stock P 4900 $10.08 Acquired 214722 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 10000 Indirect

Footnotes

F1: This includes 5,457 shares underlying deferred stock units that were granted on 12/20/2013 and fully vest on the first anniversary of the grant date, subject to the reporting person's continued service on the Board of Directors of the Issuer through the vesting date. Such shares were previously reported on a separate line on the Reporting Person's Form 3 filed 6/24/14 but are now consolidated with the Reporting Person's other direct holdings for convenience.

F2: Reflects shares owned by Richard Y. Koo, a sole proprietorship, of which the Reporting Person is the sole owner.